Quaternized chitosans, N,N,N-trimethylchitosans (TMC) with different degree of quaternization were synthesized by reacting methyl iodide with chitosan. The reaction was confirmed by FT-IR and 1 H-NMR characterization. Antimicrobial assay showed that the prepared TMC had potent biocidal effects against planktonic Gram-positive bacteria Staphylococcus epidermidis, Gramnegative bacteria Escherichia coli, and yeast Candida albicans. Bacterial and fungal biofilms were formed on poly(methyl methacrylate) (PMMA) films and then treated with TMC aqueous solutions. Zeta potential measurement suggested that TMC bonded onto the preexisting biofilms.
Introduction
Microbial biofilm formation on medical devices has been a continuing problem, often leading to serious morbidity and mortality, excess length of hospital stay, and extra costs. [1] [2] [3] [4] [5] Biofilms are likely initiated by just a few microorganisms that come into contact with and adhere to a clean surface. [6] [7] [8] [9] [10] Once adhered to the surface, microorganisms multiply and accumulate in multilayered cell clusters. Many factors, such as polysaccharide intercellular adhesin, extracellular accumulation-associated protein, physiological status changes, and intercellular signaling, can affect accumulation and biofilm formation. [11] [12] [13] [14] Microorganisms living in a biofilm are up to 1,000 times more resistant to antimicrobial agents than their planktonic counterparts. 1, [15] [16] [17] This high resistance is likely due to the combined actions of many factors, including delayed penetration of the antimicrobial agents into the biofilm matrix, the presence of neutralizing enzymes, and the expression of resistant phenotypes. 1, 5, 17 Although biofilms are firmly attached to the surface, microorganisms may dislodge from the macro-colony and drift into the environment, causing more serious problems.
Because biofilms are complex, multilayered structures, 1, 5, 7 effective approaches to disinfect preexisting biofilms should include antimicrobial agents that can bind onto biofilms and eradicate pre-attached microorganisms, which are still lacking in general practice. Here, we report that quaternized chitosans are such biofilm-binding biocides. Chitosan is a natural cationic polymer produced by deacetylation of chitin, an abundant natural polysaccharide that exists in the exoskeleton of crustaceans and the cell walls of fungi. Chitosan is hypoallergenic, biocompatible, antimicrobial, and biodegradable, making it an attractive biopolymer for biomedical applications. [18] [19] [20] [21] Since chitosan has limited water solubility under neutral and basic conditions, a range of water-soluble chitosan derivatives, including quaternized chitosans, have been prepared. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] It has been found that quaternized chitosans are antimicrobial, biocompatible, and bioadhesive, which can be potentially used in tissue engineering, permeation enhancement, drug delivery, gene delivery, and wound care. Although the activity of quaternized chitosans in killing free-swimming microorganisms and preventing the formation of biofilms on clean surfaces has been studied previously, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] the binding of quaternized chitosan onto preexisting biofilms and its effects on pre-attached microorganisms have not been reported. In this study, we found that quaternized chitosans are capable of binding onto preexisting bacterial and fungal biofilms and kill the pre-attached microbes. These findings suggest that it is feasible to use quaternized chitosans to treat preexisting biofilms and kill the pre-attached bacterial and fungal cells so as to reduce the risk of biofilm-related complications, shedding new lights on managing biofilms and controlling infections in a wide range of biomedical applications.
Results and Discussion

Preparation of Quaternized Chitosans, N,N,N-trimethylchitosan (TMC)
In the current study, the quaternized chitosans, TMC, were synthesized by reacting methyl iodide with chitosan. 32 The reaction was confirmed by FT-IR studies, as shown in Figure 1a . The bands at 3400 cm -1 , 1654 cm -1 , 1473 cm -1 , and 1150-890 cm -1 were in correspondence with the hydroxyl and amino groups, carbonyl groups, N-CH 3 groups, and the β-1,4-linked GlcN/GlcNAc saccharide structure in TMC, respectively, in good agreement with the published data. The DQ of TMC prepared with 1:1, 2:1, and 3:1 of methyl iodide to chitosan (the molar ratio of methyl iodide to the amino groups on chitosan) was 28%, 47% and 56%, respectively.
The samples were labeled as TMC28, TMC47 and TMC56 for the following studies. Their intrinsic viscosities and viscosity average molecular weights (Table 1) were tested following published procedures. 28 All the three samples were soluble in water in the pH range of 1.0-10.0. Although the biocidal mechanisms of quaternized chitosans are not completely clear, it is generally accepted that electrostatic interactions between the polycationic structure of TMC and the anionic components on microorganisms play a critical role in antibacterial activity. 23, 38 Higher DQ could lead to stronger interaction with the bacterial cell surfaces to disturb cell wall functions, and this could at least partially explain the findings in the testing of the Gram-positive bacteria S. epidermidis (Table 2 ). In the case of the Gram-negative bacteria E. coli, the MBC values were much higher than those of S. epidermidis ( was not surprising that TMC28 had a lower MBC value than TMC47 and TMC56 against E. coli.
As for C. albicans, the three TMC samples showed the same, low MBC value of 0.25 mg/mL. It was believed that the antifungal activities of TMC could also be originated from the electrostatic interactions between the cationic groups on the polymer and the anionic residues on fungal cell surfaces.
23,41-44
The absorption of TMC chains onto the fungal cell surface could block the transport of nutrients into the cells, leading to death. 45 
Binding of TMC onto Preexisting Bacterial and Fungal Biofilms
In this study, poly(methyl methacrylate) (PMMA) was selected as a typical example of biomedical materials because of its multiple dental and medical applications including complete denture bases, bone cements, screws for bone fixation, fillers for bone cavities and skull defects, and vertebrae stabilization in osteoporotic patients, in which biofilm formation is of great concerns. 46 We found that S. epidermidis, E. coli and C. albicans readily formed biofilms on the un-treated PMMA. As shown in Figure 2 , in zeta potential studies, pure PMMA film had a zeta potential of -0.08±0.15 mV, suggesting a neutral/weakly anionic surface. After the formation of S. epidermidis, E. coli or C. albicans biofilms on PMMA surfaces, the zeta-potential values were -31.31±1.81 mV, -42.32±1.57 mV, and -5.32±1.01 mV, respectively. This significant change in zeta potentials was believed to be caused by the anionic components on the microbial cells and/or the extracellular matrixes (ECMs) of the formed biofilms. [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] After TMC treatment, the biofilm-containing films were transformed into highly positively charged surfaces with zeta potentials at 17.71±1.81 mV, 12.62±1.62 mV, and 20.90±0.99 mV for S. epidermidis, E. coli and C. albicans biofilms, respectively, suggesting that TMC bonded onto the preexisting biofilms and covered the biofilm surfaces. To our best knowledge, these zeta potential and UV (using Ph-TMC as a model compound)
results are the first to demonstrate that the quaternized chitosans bind onto preexisting bacterial and fungal biofilms. This biofilm-binding activity could be due to the electrostatic interactions between the positively charged TMC polymer chains and the negatively charged microbial biofilms.
Effects of Bonded TMC against Pre-attached Bacterial and Fungal Cells
Binding of antimicrobial agents onto preexisting biofilms could increase local antimicrobial concentration within the biofilms and extend residence time, both of which could lead to potent biocidal effects against the pre-attached microorganisms. To evaluate these effects, TMC28 was used for the following study since this sample had the highest biocompatibility with model mammalian cells (see Section 2.5). The effects of TMC28 concentration in the solution on biocidal effects against the pre-attached microbes in the preexisting biofilms were shown in (Table 2) .
Again, this could be explained by the binding of TMC28 from the solution to the biofilm (Figures 2-4) , which increased the local TMC28 concentration, leading to potent antibacterial effects against the pre-attached E. coli. As discussed above, the antibacterial activities of the TMC could be originated from electrostatic interactions between TMC and the microorganisms and/or competition for divalent cations to disturb cell wall functions. Apparently, these two effects occurred rapidly, leading to fast antibacterial activities of TMC28 against the pre-attached S. epidermidis and E. coli. epidermidis and E. coli were treated for 24 h, and C. albicans were treated for 48 h).
The biocidal effects of TMC against pre-attached bacterial and fungal cells were further confirmed with SEM and CLSM/fluorescence microscopy studies. In SEM evaluations, before TMC28 treatment, a large amount of S. epidermidis (Figure 7, A) , E. coli (Figure 7, C) , and C. albicans ( Figure 7 , E) adhered and aggregated on the surface of PMMA films, forming microcolonies and developing into biofilms. After TMC28 treatment, only scattered adherent bacterial or fungal cells could be observed, some of which were of abnormal shapes ( Figure 7 , B, D, and F). CLSM studies using nucleic acid specific SYTO 9 (fluoresce green for live cells) and propidium iodide (PI, fluoresce red for dead cells) staining indicated that the dusts/abnormal shapes were caused by dead/dying S. epidermidis (Figure 8, B) or E. coli (Figure 8, D) . Similarly, fluorescence microscopic images (Figure 8 , F) using Calcofluor White M2R for staining, which was widely used to identify C. albicans, suggested that the objects with abnormal shapes were indeed dead or dying C. albicans, confirming the potent biocidal effects of TMC28 against preattached bacterial and fungal cells. Fig. 8 Representative CLSM images of pre-attached S. epidermidis and E. coli before (A and C, respectively) and after (B and D, respectively) treating with TMC28; and fluorescence microscopic images of pre-attached C. albicans before (E) and after (F) treating with TMC28. TMC28 concentration was 1.0 mg/mL. Treatment time for S. epidermidis and E. coli was 24 h, and for C. albicans was 48 h.
In vitro Biocompatibility of TMC
The biocompatibility of TMC with mammalian cells was investigated by the MTT assay using rat skin fibroblast cells as a model. As shown in Figure 9 , the viability of the fibroblast cells was not significantly affected by the presence of up to 1.0 mg/mL of TMC28 after 24 h of contact. At even higher TMC28 content, the viability was significantly decreased (p<0.05), and the half maximal inhibitory concentration was estimated to be 3.10 mg/mL (figure not shown). Since 1.0 mg/mL of TMC28 could significantly reduce the level of pre-attached microorganisms in preexisting biofilms, these findings point to great potentials of the quaternized chitosans as biocompatible, biofilm-binding biocides for a wide range of biofilm-control/infection-reduction related applications. 
Preparation of N,N,N-trimethylchitosans (TMC)
The quaternized chitosans, N,N,N-trimethylchitosans (TMC), were synthesized by reacting methyl iodide with chitosan following a previously reported procedure. in the testing of C. albicans, YM agar and broth were used, and the yeasts were grown at ambient temperature for 48 h.
Bacterial and Fungal Biofilm Formation on PMMA Films
PMMA films were fabricated by dissolving PMMA powders in acetone to prepare 10% (w/v) polymer solutions. Acetone was slowly evaporated in a fume hood. Films were cut into small pieces (0.6 cm of diameter and 0.25±0.025 cm of thickness) and sterilized with UV light.
In the preparation of microbial biofilms on PMMA films, bacteria or yeast cells were grown in the corresponding broth solutions (see the section above) and adjusted to a density of 10 [8] [9] CFU (colony forming unit)/mL. Sterile PMMA films were cultured with the microbial cells at 37 o C for 3 days (for S. epidermidis and E. coli), or at ambient temperature for 6 days (for C.
albicans) to allow microbial adhesion and biofilm formation. 
Binding of Ph-TMC onto Preexisting Bacterial and Fungal Biofilms
Biofilms of S. epidermidis, E. coli, or C. albicans on PMMA films were prepared as described above, gently washed with sterile PBS 3 times to remove non-adherent microbial cells, and The remaining film samples were further subjected to confocal laser scanning microscopy (CLSM) or fluorescence microscopy examination. In the studies of S. epidermidis and E. coli biofilms, the biofilm-containing films were exposed to nucleic acid specific SYTO 9 and propidium iodide (PI) using LIVE/DEAD ® BacLight TM Bacterial Viability Kits L7007 (Molecular Probes, Eugene, OR, USA) in dark for 15 min. CLSM observations were performed on a Olympus LSCM FV300 microscope (Tokyo, Japan) at 50 x magnification, using wavelengths of excitation 488 nm/emission 522 nm for SYTO 9 and excitation 568 nm/emission 605 nm for PI. 50 For C. albicans biofilms, the samples were stained with Calcofluor White M2R stock solution (Molecular Probes, Eugene, OR, USA) and incubated in dark for 30 min.
Fluorescence microscopy images were taken at wavelengths of excitation 358 nm/emission 461 nm.
Biocompatibility Evaluation
The biocompatibility of the TMC samples was evaluated with the MTT tests using rat skin 
